Clinical trial
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure
NCT02357615 is registered in ClinicalTrials.gov with Shanghai Shyndec Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure
- Lead sponsor
- Shanghai Shyndec Pharmaceutical Co., Ltd.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2014
- Completion date
- September 30, 2015
- Enrollment
- 244 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.